Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lancaster

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Neuroreport|November 1, 1991
Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparationJ M Lancaster, J A Davies
Experientia|August 15, 1992
Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 miceJ M Lancaster, J A Davies
Progress in Clinical and Biological Research|January 1, 1997
Recent advances in the molecular genetics of hereditary breast and ovarian cancerJ M Lancaster, R W Wiseman
Obstetrics and Gynecology|February 1, 1996
An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility geneJ M Lancaster, R W Wiseman, A Berchuck
The Journal of Bone and Joint Surgery. American Volume|October 1, 1986
Intraspinal pathways taken by sublaminar wires during removal. An experimental studyJ F Nicastro, C A Hartjen, J Traina, et al.
Molecular Carcinogenesis|July 1, 1997
Dideoxy fingerprinting assay for BRCA1 mutation analysisJ M Lancaster, A Berchuck, P A Futreal, et al.
Lancet (London, England)|July 15, 1995
p53 polymorphism in ovarian and bladder cancerJ M Lancaster, H A Brownlee, R W Wiseman, et al.
Clinical Obstetrics and Gynecology|March 21, 1998
Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2A Berchuck, M Carney, J M Lancaster, et al.
British Journal of Cancer|July 31, 1998
Progesterone receptor gene polymorphism and risk for breast and ovarian cancerJ M Lancaster, A Berchuck, M E Carney, et al.
American Journal of Obstetrics and Gynecology|May 12, 2001
Mutational analysis of the PTEN gene in human uterine sarcomasJ M Lancaster, J I Risinger, M E Carney, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Neuroreport|November 1, 1991
Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparationJ M Lancaster, J A Davies
Experientia|August 15, 1992
Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 miceJ M Lancaster, J A Davies
Progress in Clinical and Biological Research|January 1, 1997
Recent advances in the molecular genetics of hereditary breast and ovarian cancerJ M Lancaster, R W Wiseman
Obstetrics and Gynecology|February 1, 1996
An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility geneJ M Lancaster, R W Wiseman, A Berchuck
The Journal of Bone and Joint Surgery. American Volume|October 1, 1986
Intraspinal pathways taken by sublaminar wires during removal. An experimental studyJ F Nicastro, C A Hartjen, J Traina, et al.
Molecular Carcinogenesis|July 1, 1997
Dideoxy fingerprinting assay for BRCA1 mutation analysisJ M Lancaster, A Berchuck, P A Futreal, et al.
Lancet (London, England)|July 15, 1995
p53 polymorphism in ovarian and bladder cancerJ M Lancaster, H A Brownlee, R W Wiseman, et al.
Clinical Obstetrics and Gynecology|March 21, 1998
Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2A Berchuck, M Carney, J M Lancaster, et al.
British Journal of Cancer|July 31, 1998
Progesterone receptor gene polymorphism and risk for breast and ovarian cancerJ M Lancaster, A Berchuck, M E Carney, et al.
American Journal of Obstetrics and Gynecology|May 12, 2001
Mutational analysis of the PTEN gene in human uterine sarcomasJ M Lancaster, J I Risinger, M E Carney, et al.
Pageof 3